darbepoetin alfa

noun

dar·​be·​poe·​tin al·​fa ˌdär-bə-ˈpō-ə-tən-ˈal-fə, -ˈpȯi-tən- 

: a glycoprotein produced by recombinant DNA technology that is similar in amino acid sequence to human erythropoietin, stimulates the production of red blood cells, and is administered by injection especially to treat anemia (such as that associated with chronic kidney failure or chemotherapy)

Note: Darbepoetin alfa is synthesized in hamster ovary cells and is marketed under the trademark Aranesp.